SG Americas Securities LLC Has $198,000 Holdings in Cardlytics, Inc. (NASDAQ:CDLX)

SG Americas Securities LLC lifted its holdings in Cardlytics, Inc. (NASDAQ:CDLX) by 34.3% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 21,461 shares of the company’s stock after purchasing an additional 5,484 shares during the period. SG Americas Securities LLC owned 0.05% of Cardlytics worth $198,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also modified their holdings of the business. Vanguard Group Inc. lifted its stake in shares of Cardlytics by 1.8% in the 3rd quarter. Vanguard Group Inc. now owns 3,012,412 shares of the company’s stock valued at $28,317,000 after purchasing an additional 53,565 shares during the last quarter. BlackRock Inc. lifted its stake in shares of Cardlytics by 10.4% in the 2nd quarter. BlackRock Inc. now owns 2,856,513 shares of the company’s stock valued at $18,053,000 after purchasing an additional 269,375 shares during the last quarter. Baillie Gifford & Co. lifted its stake in shares of Cardlytics by 30.7% in the 4th quarter. Baillie Gifford & Co. now owns 1,436,220 shares of the company’s stock valued at $8,301,000 after purchasing an additional 337,252 shares during the last quarter. Marshall Wace LLP lifted its stake in shares of Cardlytics by 13.9% in the 2nd quarter. Marshall Wace LLP now owns 1,125,391 shares of the company’s stock valued at $7,112,000 after purchasing an additional 137,059 shares during the last quarter. Finally, Invesco Ltd. lifted its stake in shares of Cardlytics by 538.1% in the 3rd quarter. Invesco Ltd. now owns 803,241 shares of the company’s stock valued at $13,253,000 after purchasing an additional 677,354 shares during the last quarter. Institutional investors and hedge funds own 68.10% of the company’s stock.

Wall Street Analyst Weigh In

Several research firms recently issued reports on CDLX. Needham & Company LLC lifted their price objective on shares of Cardlytics from $15.00 to $17.00 and gave the company a “buy” rating in a research note on Tuesday, April 9th. Lake Street Capital boosted their target price on shares of Cardlytics from $13.00 to $18.00 and gave the stock a “buy” rating in a research report on Friday, March 15th. Finally, Craig Hallum raised shares of Cardlytics from a “hold” rating to a “buy” rating and boosted their target price for the stock from $10.00 to $18.00 in a research report on Friday, March 15th.

Insider Activity

In other news, COO Amit Gupta sold 72,658 shares of the company’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $6.10, for a total transaction of $443,213.80. Following the completion of the transaction, the chief operating officer now owns 102,342 shares of the company’s stock, valued at $624,286.20. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, insider Nicholas Hollmeyer Lynton sold 12,460 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $13.69, for a total value of $170,577.40. Following the sale, the insider now owns 71,355 shares of the company’s stock, valued at $976,849.95. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, COO Amit Gupta sold 72,658 shares of the company’s stock in a transaction dated Wednesday, January 24th. The shares were sold at an average price of $6.10, for a total transaction of $443,213.80. Following the completion of the sale, the chief operating officer now directly owns 102,342 shares in the company, valued at approximately $624,286.20. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 85,272 shares of company stock valued at $616,010. Insiders own 0.78% of the company’s stock.

Cardlytics Stock Down 5.6 %

Cardlytics stock opened at $13.57 on Friday. The firm has a market cap of $598.57 million, a price-to-earnings ratio of -3.92 and a beta of 1.44. The company has a debt-to-equity ratio of 1.91, a current ratio of 1.31 and a quick ratio of 1.31. Cardlytics, Inc. has a fifty-two week low of $4.94 and a fifty-two week high of $20.52. The firm has a fifty day moving average price of $10.26 and a two-hundred day moving average price of $9.76.

Cardlytics (NASDAQ:CDLX) last announced its quarterly earnings data on Thursday, March 14th. The company reported ($0.14) EPS for the quarter. The company had revenue of $89.17 million for the quarter. Cardlytics had a negative net margin of 43.56% and a negative return on equity of 25.38%.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.